Oncology Drugs Market Size, Share, Report & Analysis PR

1. Global Oncology Drugs Market Growth to Occur Fueled by the Worldwide Prevalence of Cancer, and the Dangerous Presence of Cancer-causing Infections by CAGR of ~8% During 2023 – 2035 Kenneth Research published a report titled “Oncology Drugs Market: Global Demand Analysis & Opportunity Outlook 2035” which delivers detailed overview of the global oncology drugs market in terms of market segmentation by drug class, indication and by region. Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market. The global oncology drugs market’s revenue is projected to grow from ~USD 148 billion in 2022 to ~USD 289 billion by the end of 2035. The market growth in the forecast period can be attributed to the universal presence of cancer, the presence of cancer-causing infections, enormous amounts spent on the development of oncology care, the growing geriatric population, and the growth in the number of drug trials in oncology.

2. The global oncology drugs market that grows at a CAGR of ~8% is segmented by indication into lung cancer, stomach cancer, colorectal cancer, breast cancer, prostate cancer, liver cancer, esophagus cancer, cervical cancer, kidney cancer, bladder cancer, and others. The breast cancer segment among these is thought to show considerable growth during the forecast period owing to vast access to screening facilities and hence the comprehensive diagnosis of this type of cancer. For more information’s@https://www.kennethresearch.com/report-details/oncology- drugs-market/10352519 Regionally, the global oncology drugs market is divided into five major parts, including North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in North America is expected to show the most significant market expansion backed by developed healthcare infrastructure, a considerable population of patients, easy drug availability, and more. The research is global in nature and covers detailed analysis on the market in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa). In addition, analysis comprising market size, Y-O-Y growth & opportunity analysis, market players’ competitive study, investment opportunities, demand for future outlook etc. has also been covered and displayed in the research report. Growing Cases of Infections Leading to Cancer to Drive Market Growth Nearly 14-21% of cancer in the world are thought to be caused by severe infections of some kind, while the World Health Organization has confirmed that ~30% of cancer

3. cases in low and lower-middle-income countries in the world develop as a result of infections including hepatitis and human papillomavirus (HPV). These infections suppress the immune system of the body, making it incapable of fighting cancer, which is the reason for their influence on the market growth. However, drug development costs, adverse effects of therapies, and drug-resistant cancer stem cells are expected to operate as key restraints to the growth of the global oncology drugs market over the forecast period. This report also provides the existing competitive scenario of some of the key players of the global oncology drugs market which includes company profiling ofAbbVie Inc., Astellas Pharma Inc., AstraZeneca PLC, Bristol Myers Squibb Company, F. Hoffmann- La Roche Ltd, Johnson & Johnson Services, Inc., Merck & Co., Inc., Novartis Pharmaceuticals Corporation, Pfizer Inc., GlaxoSmithKline plc, and others. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global oncology drugs market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future. Request Report Sample@ https://www.kennethresearch.com/sample-request- 10352519 Kenneth Research is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties.

4. Contact for more Info: AJ Daniel Email: sales@kennethresearch.com U.S. Phone: +1 313 462 0609